Okuda DT - Search Results

1

Neurofilament Light Chain Levels Are Predictive of Clinical Conversion in Radiologically Isolated Syndrome.

Rival M, Thouvenot E, Du Trieu de Terdonck L, Laurent-Chabalier S, Demattei C, Uygunoglu U, Castelnovo G, Cohen M, Okuda DT, Kantarci OH, Pelletier D, Azevedo C, Marin P, Lehmann S, Siva A, Mura T, Lebrun-Frenay C; SFSEP and RISC. Rival M, et al. Among authors: okuda dt. Neurol Neuroimmunol Neuroinflamm. 2022 Oct 24;10(1):e200044. doi: 10.1212/NXI.0000000000200044. Print 2023 Jan. Neurol Neuroimmunol Neuroinflamm. 2022. PMID: 36280258 Free PMC article.

2

Extended interval dosing of natalizumab in multiple sclerosis.

Zhovtis Ryerson L, Frohman TC, Foley J, Kister I, Weinstock-Guttman B, Tornatore C, Pandey K, Donnelly S, Pawate S, Bomprezzi R, Smith D, Kolb C, Qureshi S, Okuda D, Kalina J, Rimler Z, Green R, Monson N, Hoyt T, Bradshaw M, Fallon J, Chamot E, Bucello M, Beh S, Cutter G, Major E, Herbert J, Frohman EM. Zhovtis Ryerson L, et al. J Neurol Neurosurg Psychiatry. 2016 Aug;87(8):885-9. doi: 10.1136/jnnp-2015-312940. Epub 2016 Feb 25. J Neurol Neurosurg Psychiatry. 2016. PMID: 26917698

3

Altered task-induced cerebral blood flow and oxygen metabolism underlies motor impairment in multiple sclerosis.

West KL, Sivakolundu DK, Zuppichini MD, Turner MP, Spence JS, Lu H, Okuda DT, Rypma B. West KL, et al. Among authors: okuda dt. J Cereb Blood Flow Metab. 2021 Jan;41(1):182-193. doi: 10.1177/0271678X20908356. Epub 2020 Mar 3. J Cereb Blood Flow Metab. 2021. PMID: 32126873 Free PMC article.

4

Focal lesion in the splenium of the corpus callosum.

Okuda DT. Okuda DT. Arch Neurol. 2008 Jun;65(6):849. doi: 10.1001/archneur.65.6.849-a. Arch Neurol. 2008. PMID: 18541816 No abstract available.

5

From injection therapies to natalizumab: views on the treatment of multiple sclerosis.

Bomprezzi R, Okuda DT, Alderazi YJ, Stüve O, Frohman EM. Bomprezzi R, et al. Among authors: okuda dt. Ther Adv Neurol Disord. 2012 Mar;5(2):97-104. doi: 10.1177/1756285611431289. Ther Adv Neurol Disord. 2012. PMID: 22435074 Free PMC article.

6

Handedness and potential implications for neurorehabilitation in multiple sclerosis.

Shirani A, Okuda DT. Shirani A, et al. Among authors: okuda dt. Mult Scler Relat Disord. 2020 Jan;37:101405. doi: 10.1016/j.msard.2019.101405. Epub 2019 Sep 19. Mult Scler Relat Disord. 2020. PMID: 32172991 No abstract available.

7

Therapeutic Advances and Future Prospects in Progressive Forms of Multiple Sclerosis.

Shirani A, Okuda DT, Stüve O. Shirani A, et al. Among authors: okuda dt. Neurotherapeutics. 2016 Jan;13(1):58-69. doi: 10.1007/s13311-015-0409-z. Neurotherapeutics. 2016. PMID: 26729332 Free PMC article. Review.

8

Recurrent asymptomatic demyelinating disease following 13-cis-retinoic acid exposure.

Okuda DT, Prados MD. Okuda DT, et al. BMJ Case Rep. 2009;2009:bcr05.2009.1908. doi: 10.1136/bcr.05.2009.1908. Epub 2009 Sep 8. BMJ Case Rep. 2009. PMID: 21901115 Free PMC article.

9

Naegleria fowleri meningoencephalitis.

Okuda DT, Coons S. Okuda DT, et al. Neurology. 2003 Jul 8;61(1):E1. doi: 10.1212/01.wnl.0000058759.01260.d8. Neurology. 2003. PMID: 12847187 No abstract available.

10

Evaluation of Visual-Evoked Cerebral Metabolic Rate of Oxygen as a Diagnostic Marker in Multiple Sclerosis.

Hubbard NA, Sanchez Araujo Y, Caballero C, Ouyang M, Turner MP, Himes L, Faghihahmadabadi S, Thomas BP, Hart J, Huang H, Okuda DT, Rypma B. Hubbard NA, et al. Among authors: okuda dt. Brain Sci. 2017 Jun 11;7(6):64. doi: 10.3390/brainsci7060064. Brain Sci. 2017. PMID: 28604606 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

115 results

Search Page